Pancreatic Cancer Research

ResearcherQueen Mary University of LondonActive in the last 2 years

Silvana Debernardi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3286-8632; OpenAlex author ID A5046487897. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 8

  1. A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Developed Test for Early Detection of Pancreatic… First author DOI 10.1016/j.jmoldx.2024.10.001↗
  2. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.13576↗
  3. Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. First author DOI 10.3389/fonc.2024.1450326↗
  4. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. Co-author DOI 10.1002/ijc.34287↗
  5. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine. Co-author DOI 10.1016/j.talanta.2020.121604↗
  6. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study. Co-author DOI 10.1371/journal.pmed.1003489↗
  7. Demographic, clinical, and pathological features of early onset pancreatic cancer patients. First author DOI 10.1186/s12876-018-0866-z↗
  8. Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma. Co-author PMID 26807325↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tatjana Crnogorac‐Jurcevic · 8 shared papers, 2015–2025 · strength 1.24
  2. Oleg B. Blyuss · 4 shared papers, 2020–2025 · strength 0.73
  3. Jian Tajbakhsh · 2 shared papers, 2024–2025 · strength 0.46
  4. Stephen Jacob Pandol · 2 shared papers, 2024–2025 · strength 0.46
  5. Nirdesh K. Gupta · 2 shared papers, 2024–2025 · strength 0.46
  6. Stephen P. Pereira · 3 shared papers, 2015–2024 · strength 0.34
  7. Chara Ntala · 2 shared papers, 2018–2024 · strength 0.31
  8. Hemant Mahendrakumar Kocher · 3 shared papers, 2015–2021 · strength 0.28
  9. Simon K. Lo · 1 shared paper, 2025 · strength 0.26
  10. Nurshad Ali · 1 shared paper, 2024 · strength 0.20
  11. Łukasz Liszka · 1 shared paper, 2024 · strength 0.20
  12. Iréne Esposito · 1 shared paper, 2024 · strength 0.20
  13. Hui Cai · 1 shared paper, 2023 · strength 0.18
  14. Kirtiman Srivastava · 1 shared paper, 2023 · strength 0.18
  15. Christie Y. Jeon · 1 shared paper, 2023 · strength 0.18
  16. Xiao‐Ou Shu · 1 shared paper, 2023 · strength 0.18
  17. Qiuyin Cai · 1 shared paper, 2023 · strength 0.18
  18. Emma Daulton · 1 shared paper, 2021 · strength 0.15
  19. James Anthony Covington · 1 shared paper, 2021 · strength 0.15
  20. Alexander Ney · 1 shared paper, 2020 · strength 0.09
  21. Núria Malats · 1 shared paper, 2020 · strength 0.09
  22. William Greenhalf · 1 shared paper, 2020 · strength 0.09
  23. Eithne Costello · 1 shared paper, 2020 · strength 0.09
  24. Tomasz P. Radon · 1 shared paper, 2015 · strength 0.04
  25. Claude Chelala · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.